CLINICAL_TRIALS
trial_result
· 2018-07-03
Clinical Trial Update: A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of alteplase in participants with mild stroke was terminated; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Stroke | Phase 3 | Status: TERMINATED | Results posted: 2018-07-03